Dr. Helmut O Steinberg

International Journal of Endocrinology Research

Medicine-Endocrinology

Name: Dr. Helmut O Steinberg

Educational Qualification: PhD

Designation: Professor of Medicine-Endocrinology at The University of Tennessee Health Science Center

Department: Medicine-Endocrinology

The University of Tennessee Health Science Center

Email: hsteinb1@uthsc.edu

Research Interests: 1. Diabetes and general endocrinology in the hospital and outpatient setting 2. Management of chronic diseases 3. Behavioral determinants of successful glucose and risk factor control 4. Diabetes, Endocrinology, and Metabolism 5. Insulin resistance and vascular reactivity 6. Effect of macronutrients on markers of vascular function 7. Management of chronic diseases 8. Drug development

Biography: Dr. Helmut O Steinberg is an endocrinologist in Indianapolis, Indiana and is affiliated with multiple hospitals in the area, including Baptist Memorial Hospital-Memphis and Methodist Hospitals of Memphis. He received his medical degree from Ruprecht Karl University Faculty of Medicine and has been in practice for more than 20 years. Dr. Steinberg accepts several types of health insurance. He is one of 23 doctors at Baptist Memorial Hospital-Memphis and one of 11 at Methodist Hospitals of Memphis who specialize in Endocrinology, Diabetes & Metabolism.

Shankar, SS, Shankar, RR, Mixson, LA, Miller, DL, Chung, C, Cilissen, C, Beals, CR, Stoch, SA, Steinberg, HO, Kelley, DE. Linearity of β-cell response across the metabolic spectrum and to pharmacology: insights from a graded glucose infusion-based investigation series. Am J Physiol Endocrinol Metab, 310 (11), E865-73, 2016.
Steinberg, HO. Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes. Postgrad Med, 128 (4), 398-408, 2016.
Prospective Association of GLUL rs10911021 With Cardiovascular Morbidity and Mortality Among Individuals with Type 2 Diabetes: The Look AHEAD Study. Diabetes, 65 (1), 297-302, 2016.
Shankar, SS, Shankar, RR, Railkar, RA, Beals, CR, Steinberg, HO, Kelley, DE. Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population. Curr Ther Res Clin Exp, 77, 83-9, 2015.
Steinberg, H, Jacovino, C, Kitabchi, AE. Look inside Look AHEAD: why the glass is more than half-full. Curr Diab Rep, 14 (7), 500, 2014.
Steinberg, H, Anderson, MS, Musliner, T, Hanson, ME, Engel, SS. Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin. Vasc Health Risk Manag, 9, 273-82, 2013.
Mather, KJ, Steinberg, HO, Baron, AD. Insulin resistance in the vasculature. J Clin Invest, 123 (3), 1003-4, 2013.
Fonseca, V, Staels, B, Morgan, JD, Shentu, Y, Golm, GT, Johnson-Levonas, AO, Kaufman, KD, Goldstein, BJ, Steinberg, H. Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes. J Diabetes Complications, 27 (2), 177-83, 2012.
Barzilai, N, Guo, H, Mahoney, EM, Caporossi, S, Golm, GT, Langdon, RB, Williams-Herman, D, Kaufman, KD, Amatruda, JM, Goldstein, BJ, Steinberg, H. Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Curr Med Res Opin, 27 (5), 1049-58, 2011.
Shankar, SS, Steinberg, HO. Weight loss and vascular function: the good and the unknown. Hypertension, 52 (1), 57-8, 2008.
Bax, JJ, Young, LH, Frye, RL, Bonow, RO, Steinberg, HO, Barrett, EJ, ,. Screening for coronary artery disease in patients with diabetes. Diabetes Care, 30 (10), 2729-36, 2007.
Hardy, TA, Meyers, AL, Yu, J, Shankar, SS, Steinberg, HO, Porksen, NK. Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks. Diabetes Care, 30 (1), 157-8, 2007.
Shankar, SS, Considine, RV, Gorski, JC, Steinberg, HO. Insulin sensitivity is preserved despite disrupted endothelial function. Am J Physiol Endocrinol Metab, 291 (4), E691-6, 2006.
Bell, LN, Ward, JL, Degawa-Yamauchi, M, Bovenkerk, JE, Jones, R, Cacucci, BM, Gupta, CE, Sheridan, C, Sheridan, K, Shankar, SS, Steinberg, HO, March, KL, Considine, RV. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab, 291 (4), E843-8, 2006.
Shankar, SS, DubÃ©, MP, Gorski, JC, Klaunig, JE, Steinberg, HO. Indinavir impairs endothelial function in healthy HIV-negative men. Am Heart J, 150 (5), 933, 2005.
Shankar, SS, Steinberg, HO. FFAs: do they play a role in vascular disease in the insulin resistance syndrome. Curr Diab Rep, 5 (1), 30-5, 2005.
Shankar, SS, Steinberg, HO. Obesity and endothelial dysfunction. Semin Vasc Med, 5 (1), 56-64, 2005.
Shankar, SS, Mirzamohammadi, B, Walsh, JP, Steinberg, HO. L-carnitine may attenuate free fatty acid-induced endothelial dysfunction. Ann N Y Acad Sci, 1033, 189-97, 2004.
Mather, KJ, Lteif, A, Steinberg, HO, Baron, AD. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes, 53 (8), 2060-6, 2004.

Serial no:IIEBM0574

Download Certificate

Dr. Helmut O Steinberg

International Journal of Endocrinology Research

Medicine-Endocrinology

Guidelines

Quick Links

Subscribe